In-Ho Kim

851 total citations
40 papers, 626 citations indexed

About

In-Ho Kim is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, In-Ho Kim has authored 40 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 13 papers in Surgery. Recurrent topics in In-Ho Kim's work include Gastric Cancer Management and Outcomes (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Colorectal Cancer Treatments and Studies (6 papers). In-Ho Kim is often cited by papers focused on Gastric Cancer Management and Outcomes (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Colorectal Cancer Treatments and Studies (6 papers). In-Ho Kim collaborates with scholars based in South Korea, United States and China. In-Ho Kim's co-authors include Kyung‐Ah Jung, Daeseok Han, Hyo Jin Lee, Hyunho Kim, Myung Ah Lee, Moon Hyung Choi, Tae Ho Hong, Ji Eun Lee, Ji Youl Lee and Sook Hee Hong and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

In-Ho Kim

36 papers receiving 603 citations

Peers

In-Ho Kim
Yin Li China
Sookyung Lee South Korea
In-Ho Kim
Citations per year, relative to In-Ho Kim In-Ho Kim (= 1×) peers Liqing Jiang

Countries citing papers authored by In-Ho Kim

Since Specialization
Citations

This map shows the geographic impact of In-Ho Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by In-Ho Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites In-Ho Kim more than expected).

Fields of papers citing papers by In-Ho Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by In-Ho Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by In-Ho Kim. The network helps show where In-Ho Kim may publish in the future.

Co-authorship network of co-authors of In-Ho Kim

This figure shows the co-authorship network connecting the top 25 collaborators of In-Ho Kim. A scholar is included among the top collaborators of In-Ho Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with In-Ho Kim. In-Ho Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cho, Dong‐Woo, Tae Ho Hong, Sung Hak Lee, et al.. (2025). Clinical and Molecular Characteristics of KRAS Codon-Specific Mutations in Advanced Pancreatic Ductal Adenocarcinoma with Prognostic and Therapeutic Implications. International Journal of Molecular Sciences. 26(22). 10908–10908.
2.
Lee, Keun Wook, Devalingam Mahalingam, Byoung Yong Shim, et al.. (2025). DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B. Nature Communications. 16(1). 6393–6393.
4.
Park, Se Jun, et al.. (2023). Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overexpression. Journal of Clinical Medicine. 12(16). 5394–5394. 15 indexed citations
7.
Park, Inkeun, In-Ho Kim, Joon Young Hur, et al.. (2022). Prognostic model in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors after platinum failure. Current Problems in Cancer. 46(3). 100848–100848. 8 indexed citations
8.
Kim, In-Ho & Hyo Jin Lee. (2022). The Frontline Immunotherapy-Based Treatment of Advanced Clear Cell Renal Cell Carcinoma: Current Evidence and Clinical Perspective. Biomedicines. 10(2). 251–251. 16 indexed citations
9.
Kim, Hyunho, Myung Ah Lee, Ji Youl Lee, et al.. (2021). Prognostic Impact of APOBEC3B Expression in Metastatic Urothelial Carcinoma and Its Association with Tumor-Infiltrating Cytotoxic T Cells. Current Oncology. 28(3). 1652–1662. 7 indexed citations
10.
Kim, In-Ho, Moon Hyung Choi, In Seok Lee, Tae Ho Hong, & Myung Ah Lee. (2021). Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study. BMC Cancer. 21(1). 77–77. 48 indexed citations
11.
Kim, In-Ho & Hyo Jin Lee. (2021). Perioperative Systemic Treatment for Muscle-Invasive Bladder Cancer: Current Evidence and Future Perspectives. International Journal of Molecular Sciences. 22(13). 7201–7201. 17 indexed citations
12.
Lee, Chul Seung, Daeyoun David Won, Soon Nam Oh, et al.. (2020). Prognostic role of pre-sarcopenia and body composition with long-term outcomes in obstructive colorectal cancer: a retrospective cohort study. World Journal of Surgical Oncology. 18(1). 230–230. 26 indexed citations
13.
Kim, In-Ho & Hyo Jin Lee. (2020). Perioperative immunotherapy for muscle-invasive bladder cancer. Translational Andrology and Urology. 9(6). 2976–2985. 8 indexed citations
14.
Kim, In-Ho, Ji Eun Lee, Ji Hyun Yang, et al.. (2017). Clinical Significance of Discordance between Carcinoembryonic Antigen Levels and RECIST in Metastatic Colorectal Cancer. Cancer Research and Treatment. 50(1). 283–292. 6 indexed citations
15.
Kim, In-Ho, Sook Hee Hong, Tae Jung Kim, et al.. (2016). Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 17(5). e31–e43. 11 indexed citations
16.
Lee, Jieun, Myung Ah Lee, In-Ho Kim, & Sang-Young Roh. (2016). Clinical characteristics of young-age onset gastric cancer in Korea. BMC Gastroenterology. 16(1). 110–110. 21 indexed citations
17.
Kim, In-Ho, Sook Hee Hong, Tae Jung Kim, et al.. (2016). Clinical Significance of C-MET Overexpression and Epidermal Growth Factor Receptor Mutation in Platinum-Based Adjuvant Chemotherapy Outcome in Surgically Resected Lung Adenocarcinoma. Annals of Surgical Oncology. 24(3). 770–777. 8 indexed citations
18.
Lee, Jieun, In-Ho Kim, Jin Su Kim, et al.. (2016). Different clinical characteristics in sporadic young-age onset colorectal cancer. Medicine. 95(37). e4840–e4840. 12 indexed citations
19.
Kim, In-Ho, et al.. (2010). Complications of Tonsillectomy. Maxillofacial Plastic and Reconstructive Surgery. 32(5). 437–441. 1 indexed citations
20.
Lyu, Ha-Na, Myoung‐Chong Song, Dae‐Young Lee, et al.. (2007). Development of Biologically Active Compounds from Edible Plant Sources XVIII. Isolation of Derivatives of Ergosterol from the Fruit Body of Phellinus linteus. Applied Biological Chemistry. 50(1). 57–62. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026